MediPharm Labs Corp. (TSE:LABS – Get Free Report)’s stock price hit a new 52-week low on Tuesday . The stock traded as low as C$0.06 and last traded at C$0.06, with a volume of 185410 shares traded. The stock had previously closed at C$0.07.
MediPharm Labs Stock Performance
The company has a market capitalization of C$26.72 million, a price-to-earnings ratio of -1.63 and a beta of 0.88. The company has a debt-to-equity ratio of 5.90, a quick ratio of 3.10 and a current ratio of 3.11. The business’s 50-day simple moving average is C$0.07 and its 200-day simple moving average is C$0.07.
About MediPharm Labs
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.
Featured Stories
- Five stocks we like better than MediPharm Labs
- With Risk Tolerance, One Size Does Not Fit All
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- How to Use Stock Screeners to Find Stocks
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- How to Calculate Options Profits
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
